
Ivermectin’s potential in adjuvant cancer therapy? Exploring its potential effects
Ivermectin, a well-known anti-parasitic drug, has recently garnered attention for its potential role in cancer adjunctive therapy. While its primary use is for treating parasitic infections, studies suggest that Ivermectin might play unexpected roles in inhibiting cancer cell growth, enhancing treatment efficacy, and supporting the immune system.








